LY2033298
SIGMA/L9919 - ≥98% (HPLC)
Synonym: 3-
CAS Number: 886047-13-8
Empirical Formula (Hill Notation): C13H14ClN3O2S
Molecular Weight: 311.79
MDL Number: MFCD12912423
Linear Formula: C13H14ClN3O2S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white to tan |
| form | solid |
| InChI | 1S/C13H14ClN3O2S/c1-5-7-9 |
| InChI key | CTEGQKDJTBWFHW-UHFFFAOYSA |
| originator | Eli Lilly |
| Quality Level | 100  |
| SMILES string | COc1nc2sc(C(=O)NC3CC3)c(N |
| solubility | DMSO: >20 mg/mL |
| storage condition | desiccated |
| storage temp. | −20°C |
| Biochem/physiol Actions: | LY2033298 is a positive allosteric modulator of muscarinic M4 receptor. |
| Biochem/physiol Actions: | LY2033298 is a robust allosteric potentiator that is highly selective for the human M4 muscarinic acetylcholine receptor subtype. LY2033298 potentiates ACh-M4 binding, with no effect at M1/3/5 receptors. LY2033298 can also bind to the M ACh receptor, and mediate either positive or negative allosteric effects depending on the ligand used to probe receptor activity. |
| Features and Benefits: | This compound was developed by Eli Lilly . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol |  GHS08 |
| Signal word | Danger |
| Hazard statements | H334 |
| Precautionary statements | P261 - P284 - P501 |
| Hazard Codes | Xi |
| Risk Statements | 43 |
| Safety Statements | 36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |